We are live on ! Find out more
AGP

Aspire Growth Partners Portfolio holdings

AUM $172M
1-Year Est. Return 33.61%
This Fund
S&P 500
This Quarter Est. Return
+1.16%
1 Year Est. Return
+33.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$102M
AUM Growth
–
Cap. Flow
+$103M
Cap. Flow %
101%
Top 10 Hldgs %
45.89%
Holding
99
New
99
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$9.99M
2
AAPL icon
Apple
AAPL
+$8.89M
3
VOOV icon
Vanguard S&P 500 Value ETF
VOOV
+$6.98M
4
MSFT icon
Microsoft
MSFT
+$5.6M
5
QQQM icon
Invesco NASDAQ 100 ETF
QQQM
+$3.43M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 21.95%
2 Consumer Discretionary 6.19%
3 Financials 6%
4 Healthcare 5.74%
5 Communication Services 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBY icon
76
Best Buy
BBY
$18.2B
$338K 0.33%
+3,934
New +$359K
MCD icon
77
McDonald's
MCD
$192B
$337K 0.33%
+1,159
New +$346K
VIG icon
78
Vanguard Dividend Appreciation ETF
VIG
$111B
$328K 0.32%
+1,677
New +$335K
COST icon
79
Costco
COST
$422B
$309K 0.3%
+337
New +$313K
IWF icon
80
iShares Russell 1000 Growth ETF
IWF
$121B
$300K 0.29%
+2,992
New +$294K
MU icon
81
Micron Technology
MU
$930B
$295K 0.29%
+3,390
New +$345K
TSLA icon
82
Tesla
TSLA
$1.23T
$286K 0.28%
+720
New +$232K
FIS icon
83
Fidelity National Information Services
FIS
$23.1B
$278K 0.27%
+3,447
New +$297K
BA icon
84
Boeing
BA
$171B
$275K 0.27%
+1,555
New +$244K
GGG icon
85
Graco
GGG
$12.9B
$255K 0.25%
+3,020
New +$262K
RJF icon
86
Raymond James Financial
RJF
$33.8B
$249K 0.24%
+1,602
New +$242K
CVS icon
87
CVS Health
CVS
$133B
$242K 0.24%
+5,396
New +$303K
IQV icon
88
IQVIA
IQV
$38.7B
$241K 0.24%
+1,226
New +$259K
GE icon
89
GE Aerospace
GE
$374B
$238K 0.23%
+1,424
New +$254K
EW icon
90
Edwards Lifesciences
EW
$49.6B
$237K 0.23%
+3,199
New +$224K
CMG icon
91
Chipotle Mexican Grill
CMG
$47.2B
$235K 0.23%
+3,904
New +$235K
O icon
92
Realty Income
O
$59.6B
$231K 0.23%
+4,328
New +$252K
TMO icon
93
Thermo Fisher Scientific
TMO
$213B
$219K 0.21%
+421
New +$231K
SPGI icon
94
S&P Global
SPGI
$121B
$212K 0.21%
+425
New +$216K
BMY icon
95
Bristol-Myers Squibb
BMY
$133B
$208K 0.2%
+3,684
New +$206K
SYK icon
96
Stryker
SYK
$125B
$208K 0.2%
+577
New +$214K
NEE icon
97
NextEra Energy
NEE
$181B
$201K 0.2%
+2,806
New +$218K
QCOM icon
98
Qualcomm
QCOM
$155B
$201K 0.2%
+1,306
New +$214K
CTMX icon
99
CytomX Therapeutics
CTMX
$675M
$42K 0.04%
+40,780
New +$43.9K
1 2 3
4

Similar funds

BIA
Benchmark Investment Advisors Chicago, Illinois $172M AUM
CRFG
Columbia River Financial Group Vancouver, Washington $172M AUM 13.74% 1-Year Est. Return
SPF
South Plains Financial Lubbock, Texas $172M AUM 21.06% 1-Year Est. Return
TA
Tiptree Advisors New York $172M AUM 86.65% 1-Year Est. Return
GWCM
Godshalk Welsh Capital Management Radnor, Pennsylvania $172M AUM 16.03% 1-Year Est. Return
AIM
Atlantic Investment Management New York $172M AUM 39.5% 1-Year Est. Return
BAM
Bullseye Asset Management Denver, Colorado $173M AUM 9.48% 1-Year Est. Return
CCM
Ciovacco Capital Management Atlanta, Georgia $172M AUM 21.38% 1-Year Est. Return

Aspire Growth Partners's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Aspire Growth Partners, which disclosed 99 positions worth $102M. Its ten largest holdings account for 46% of the portfolio.

Its largest position is Vanguard S&P 500 ETF: 18,438 shares worth $9.93M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, followed by Consumer Discretionary and Financials.

  • Aspire Growth Partners's largest Q4 2024 buy was Vanguard S&P 500 ETF: 18,438 shares worth $9.93M.
  • Aspire Growth Partners's ten largest holdings make up 46% of its $102M portfolio in Q4 2024.
  • Aspire Growth Partners disclosed 99 positions in Q4 2024, its first 13F filing on record.

Based on Aspire Growth Partners's 13F filing for Q4 2024, filed 14 Feb 2025.